Reckitt Benckiser: Laxman Narasimhan steps down as CEO, Nicandro Durante appointed Ruchika Sharma3 Sept 2022 2:00 PM ISTNew Delhi: Reckitt Benckiser Group plc has announced that its CEO, Laxman Narasimhan will step down as Chief Executive Officer on September 30, 2022....
Lupin, Zydus Lifesciences recall products in US over manufacturing issues Ruchika Sharma3 Sept 2022 12:03 PM ISTNew Delhi: Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world's largest market for medicines, due to...
Boehringer Ingelheim gets USFDA nod for SPEVIGO to treat generalized pustular psoriasis flares Ruchika Sharma3 Sept 2022 11:00 AM ISTRidgefield: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has approved SPEVIGO, the first approved treatment...
Philips arm to pay over Rs 191 crore for alleged false claims for respiratory-related medical equipment Ruchika Sharma3 Sept 2022 10:00 AM ISTA Philips spokesperson said its subsidiary agreed to settle the claim to avoid the required expense of litigating the allegations.
Sanofi gets USFDA nod for ASMD drug Xenpozyme Ruchika Sharma2 Sept 2022 3:57 PM ISTASMD, historically known as Niemann-Pick disease types A, A/B, and B, is an extremely rare, progressive genetic disease with significant morbidity and...
Department of Pharmaceuticals grants 'in-Principle' nod to 3 states to set up bulk drug parks Ruchika Sharma2 Sept 2022 3:00 PM ISTMaximum assistance under the scheme for one Bulk Drug Park would be limited to Rs. 1000 crores.
Pfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for 12 years and older Ruchika Sharma2 Sept 2022 2:00 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
CDSCO panel recommends Biological E 14-valent paediatric vaccine against S pneumonia Ruchika Sharma2 Sept 2022 12:55 PM ISTNew Delhi: Biological E Limited on Thursday announced that the Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO)...
Aurobindo Pharma plans to infuse around Rs 300 crore for biologics manufacturing facilities Ruchika Sharma2 Sept 2022 12:11 PM ISTThe board approved entering into contract manufacturing operations (CMO) for biologicals for effective utilisation of capacities.
Adar Poonawalla says SII will try to to launch Omicron-specific vaccine after six months Ruchika Sharma2 Sept 2022 11:00 AM ISTSerum Institute is working with US biotechnology major Novavax to bring the Omicron-specific vaccine.
Biocon arm gets multiple USFDA observations across India, Malaysia Ruchika Sharma1 Sept 2022 5:00 PM ISTBiocon said the inspections were on account of three pre-approval inspections for biosimilar Bevacizumab, rh-Insulin and Insulin Aspart and a capacity...
SII qHPV vaccine against cervical cancer to be launched by year-end, to be priced between Rs 200-400: Adar Poonawalla Ruchika Sharma1 Sept 2022 4:20 PM IST"The vaccine would be much much less in price as compared to other vaccines for cervical cancer," Poonawalla said.
